- Home
- BWB vs FDMT Comparison
BWB vs FDMT Comparison
Compare BWB & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWB
- FDMT
- Stock Information
- Founded
- BWB 2005
- FDMT 2013
- Country
- BWB United States
- FDMT United States
- Employees
- BWB N/A
- FDMT N/A
- Industry
- BWB Major Banks
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- BWB Finance
- FDMT Health Care
- Exchange
- BWB Nasdaq
- FDMT Nasdaq
- Market Cap
- BWB 442.3M
- FDMT 391.8M
- IPO Year
- BWB 2018
- FDMT 2020
- Fundamental
- Price
- BWB $16.46
- FDMT $11.50
- Analyst Decision
- BWB Strong Buy
- FDMT Strong Buy
- Analyst Count
- BWB 2
- FDMT 9
- Target Price
- BWB $20.50
- FDMT $30.11
- AVG Volume (30 Days)
- BWB 134.9K
- FDMT 933.7K
- Earning Date
- BWB 10-21-2025
- FDMT 11-07-2025
- Dividend Yield
- BWB N/A
- FDMT N/A
- EPS Growth
- BWB 25.72
- FDMT N/A
- EPS
- BWB 1.32
- FDMT N/A
- Revenue
- BWB $127,243,000.00
- FDMT $33,000.00
- Revenue This Year
- BWB $35.74
- FDMT $9,656.76
- Revenue Next Year
- BWB $12.55
- FDMT N/A
- P/E Ratio
- BWB $12.47
- FDMT N/A
- Revenue Growth
- BWB 20.40
- FDMT N/A
- 52 Week Low
- BWB $11.93
- FDMT $2.24
- 52 Week High
- BWB $18.01
- FDMT $12.34
- Technical
- Relative Strength Index (RSI)
- BWB 44.35
- FDMT 63.45
- Support Level
- BWB $16.30
- FDMT $11.09
- Resistance Level
- BWB $17.14
- FDMT $12.34
- Average True Range (ATR)
- BWB 0.68
- FDMT 0.90
- MACD
- BWB -0.11
- FDMT 0.01
- Stochastic Oscillator
- BWB 19.77
- FDMT 71.43
About BWB Bridgewater Bancshares Inc.
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.